Inside information announcement - nmpa approval of batoclimab injection (subcutaneous injection) for the treatment of generalized myasthenia gravis
Filed with HKEX · Stock code 2142 ·
6ix is reading this filing.
View original source (HKEXnews)HBM Holdings Ltd. on 6ix
Earlier from HBM
- Next Day Disclosure Return
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
- Supplemental announcement in relation to the 2025 annual report and the 2026 interim report
- Voluntary announcement - nona biosciences develops the world's first language model trained on fully human heavy-chain-only antibodies
- Harbour BioMed Announces U.S. FDA IND Clearance for HBM7004 for the Treatment of Advanced Solid Tumors
Follow HBM into a list and get an email when it puts out news.
Follow HBM